Phase 1 Osteoarthritis Trial, Recruiting NCT04929951 Sponsor: Stanford University Condition: Osteoarthritis
Back to Osteoarthritis

Phase 1 Osteoarthritis Trial, Recruiting

NCT04929951
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 25 and 75 years old
  • People who have already been diagnosed with osteoarthritis (joint wear and tear) in the shoulder joint (where the upper arm bone meets the shoulder socket)
  • People who can understand and communicate in English well enough to understand what the procedure involves
  • People who are able to give their informed agreement to participate
  • People who are able to complete follow-up surveys online, by phone, or in person
  • People who are able to understand instructions for care before and after the procedure
  • People who are able to walk around on their own at the start of the trial
  • People who have already tried at least 6 weeks of physical therapy and anti-inflammatory medications (if suitable for them), with or without bracing or injections, and have not had enough improvement from those treatments

Who may not be able to join:

  • People younger than 25 or older than 75 years old
  • People whose shoulder X-rays show very little or no osteoarthritis, or very severe osteoarthritis where the bones are rubbing directly together
  • People who have previously had a full or partial shoulder joint replacement, or surgery to regrow cartilage in the joint
  • People who have received a cortisone, PRP, or hyaluronic acid injection into the joint within the past 3 months
  • People who have an inflammatory or rheumatological condition such as rheumatoid arthritis
  • People who are currently taking medication that affects the immune system
  • People who have an uncontrolled hormonal or gland-related condition (such as uncontrolled thyroid or diabetes-related disorders) (confirm with trial site)
  • People with a BMI over 40, or whose joint space cannot be seen clearly on ultrasound
  • People with a current bone infection, HIV, hepatitis C, active infection, or poorly controlled diabetes (with a blood sugar marker called HbA1c above 7.0)
  • People who are pregnant or planning to become pregnant
  • People who have previously had a stem cell injection into the shoulder joint being considered for the trial
  • People who are scheduled for shoulder surgery or any other surgery that might affect the trial results
  • People who have a blood clotting disorder or are taking blood-thinning medication
  • People experiencing long-term pain across multiple parts of the body, or who are being treated with opioid pain medications
  • People who have been diagnosed with fibromyalgia
  • People who have a large rotator cuff tear involving two or more tendons that have pulled away from their normal position

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
28 July 2022
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

ASES Shoulder Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov